Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskPositive

Pelthos Therapeutics Inc.

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

pelthostherapeutics.com
Filed: Sep 29, 2026Freehold, New JerseyCIK: 0001919246Healthcare
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Pelthos Therapeutics Inc. stockholders approved the 2026 Equity Incentive Plan on September 29, 2026, replacing the 2023 plan to enhance talent retention and competitiveness in the biopharmaceutical industry.

Key Takeaways

The 2026 Equity Incentive Plan was approved by stockholders at the Annual Meeting on September 29, 2026

The new plan replaces the previous 2023 Equity Incentive Plan and became effective immediately upon stockholder approval

2 more takeaways

Filing Overview

Form Type8-K
Filing DateSep 29, 2026
Item5.02
CategoryExecutive Change
CIK0001919246
Accession #0001919246-26-000125
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
material agreement

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

Pelthos Therapeutics Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.